MedPath

Exposure Initializes Therapy - Treatment Of Homebound Patients Extended

Not Applicable
Conditions
Agoraphobia
Interventions
Behavioral: cognitive behavioral therapy
Registration Number
NCT04460378
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

Cognitive behavioral treatment of homebound patients with severe agoraphobia.

Detailed Description

Homebound patients with severe agoraphobia are treated with an exposure focussed cognitive behavioral therapy. The treatment begins at home. With a quick onset of guided exposure, patients get the possibility to develope the capability to reach the regular Treatment Location on their own very rapidly.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • agoraphobia with/without Panic disorder
Exclusion Criteria
  • psychotic disorders
  • bipolar disorders
  • acute substance dependency

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cognitive Behavioral Therapycognitive behavioral therapyManualized Cognitive Behavioral Therapy starting at the patients' home.
Primary Outcome Measures
NameTimeMethod
MIChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Mobility Inventory

Secondary Outcome Measures
NameTimeMethod
rs 13Change from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Resilienzskala (resilience scale)

NEO-FFIChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Persönlichkeitsfragebogen (personality inventory)

BSQChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Bosy Sensation Questionnaire

ASIChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Angstsensitivität (anxiety sensitivity)

AKFChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Angst-Kontroll-Fragebogen (anxiety control)

SWEChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Selbstwirksamkeitsfragebogen (self-efficacy questionnaire)

UI18Change from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Unsicherheitsintoleranz Fragebogen (intolerance of uncertainty questionnaire)

ACQChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Agoraphobic cognition questionnaire

BDI IIChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Beck Depression inventory II

alpha-amylasechange from baseline to follow up (+98 days)

daily profile of salivary alpha amylase

PSQ 20Change from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

perceived stress questionnaire

cortisolchange from baseline to follow up (+98 days)

daily profile of salivary cortisol

PASChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Panik- und Agoraphobie-Skala (Panic and agoraphobia scale)

EQ-5DChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

life quality questionnaire

AAQ IIChange from baseline to 4th psychotherapy session (+42 days) and change from baseline to the 9th psychotherapy session (+60 days) and change from baseline to follow up (+98 days)

Acceptance and Action questionnaire

Trial Locations

Locations (1)

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath